Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurologist-Initiated Treatment of Hypertension and Hyperlipidemia in Epilepsy
NCT05704439Withdrawn
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2024
- Primary completion
- Jan 2027
01
Overview
Randomised, open-label trial in hypertension (HTN) and hyperlipidemia (2 arms), sponsored by University of California, Los Angeles. Primary endpoint: Change in ACC-ASCVD score from baseline at 3 months. Planned start Jan 2024; status: withdrawn.
02
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT05704439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05704439.